127 related articles for article (PubMed ID: 25473809)
1. Nanotechnology in medicine: European research and its implications.
Hofmann-Amtenbrink M; Hofmann H; Hool A; Roubert F
Swiss Med Wkly; 2014; 144():w14044. PubMed ID: 25473809
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnological applications in medicine.
Caruthers SD; Wickline SA; Lanza GM
Curr Opin Biotechnol; 2007 Feb; 18(1):26-30. PubMed ID: 17254762
[TBL] [Abstract][Full Text] [Related]
3. Unique benefits of nanotechnology to drug delivery and diagnostics.
McNeil SE
Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology and nuclear medicine; research and preclinical applications.
Assadi M; Afrasiabi K; Nabipour I; Seyedabadi M
Hell J Nucl Med; 2011; 14(2):149-59. PubMed ID: 21761018
[TBL] [Abstract][Full Text] [Related]
5. A perspective on bioconjugated nanoparticles and quantum dots.
Huo Q
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):1-10. PubMed ID: 17544637
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
7. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.
Hartshorn CM; Russell LM; Grodzinski P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Applications of Quantum Dots.
Gour A; Ramteke S; Jain NK
AAPS PharmSciTech; 2021 Sep; 22(7):233. PubMed ID: 34476619
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnological medical devices and nanopharmaceuticals: the European regulatory framework and research needs.
Rickerby DG
J Nanosci Nanotechnol; 2007 Dec; 7(12):4618-25. PubMed ID: 18283854
[TBL] [Abstract][Full Text] [Related]
10. Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
Satalkar P; Elger BS; Shaw DM
Sci Eng Ethics; 2016 Oct; 22(5):1255-1276. PubMed ID: 26373718
[TBL] [Abstract][Full Text] [Related]
11. Emerging translational research on magnetic nanoparticles for regenerative medicine.
Gao Y; Lim J; Teoh SH; Xu C
Chem Soc Rev; 2015 Oct; 44(17):6306-29. PubMed ID: 26505058
[TBL] [Abstract][Full Text] [Related]
12. Magnetic quantum dots in biotechnology--synthesis and applications.
Mahajan KD; Fan Q; Dorcéna J; Ruan G; Winter JO
Biotechnol J; 2013 Dec; 8(12):1424-34. PubMed ID: 24105975
[TBL] [Abstract][Full Text] [Related]
13. Towards the use of nanoparticles in cancer therapy and imaging.
Pauwels EK; Erba P
Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
[TBL] [Abstract][Full Text] [Related]
14. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
15. Europe as leaders in nanomedicine: let's go for it!
Lévy L
Nanomedicine (Lond); 2014 Apr; 9(4):389-91. PubMed ID: 24787438
[No Abstract] [Full Text] [Related]
16. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
Szebeni J
Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
[TBL] [Abstract][Full Text] [Related]
17. Challenges in design of translational nanocarriers.
Sun Q; Radosz M; Shen Y
J Control Release; 2012 Dec; 164(2):156-69. PubMed ID: 22664472
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in the therapeutic applications of nanotechnology.
Solomon M; D'Souza GG
Curr Opin Pediatr; 2011 Apr; 23(2):215-20. PubMed ID: 21412081
[TBL] [Abstract][Full Text] [Related]
19. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
[TBL] [Abstract][Full Text] [Related]
20. Beyond biotechnology: FDA regulation of nanomedicine.
Miller J
Columbia Sci Technol Law Rev; 2003; 4():E5. PubMed ID: 15977335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
